Effect of voriconazole on the pharmacokinetics of diclofenac

scientific article published in December 2007

Effect of voriconazole on the pharmacokinetics of diclofenac is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1472-8206.2007.00516.X
P698PubMed publication ID18034666

P50authorPertti J. NeuvonenQ23039874
Klaus OlkkolaQ38804752
P2093author name stringKari Leino
Anders Rane
Stefan Lundgren
Kari Laine
Mika Valtonen
Ville-Veikko Hynninen
P2860cites workHepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathwaysQ28679171
Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronideQ30747312
Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidationQ31034463
Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of riskQ34518911
Influence of age and cytochrome P450 2C9 genotype on the steady-state disposition of diclofenac and celecoxibQ34531655
Bioavailability of diclofenac potassium at low dosesQ35827287
Development and validation of a high-performance liquid chromatography assay for voriconazoleQ39776152
Voriconazole potentiates warfarin‐induced prothrombin time prolongationQ42029509
Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humansQ42284291
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-IbuprofenQ42408726
Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and tolerationQ42760098
Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenacQ43569654
The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitroQ43877657
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolamQ48710479
P433issue6
P921main subjectvoriconazoleQ412236
DiclofenacQ244408
pharmacokineticsQ323936
P304page(s)651-656
P577publication date2007-12-01
P1433published inFundamental and Clinical PharmacologyQ15760364
P1476titleEffect of voriconazole on the pharmacokinetics of diclofenac
P478volume21